Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.

Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H, Li J, Broelsch CE.

Ann Surg. 2010 Nov;252(5):850-6. doi: 10.1097/SLA.0b013e3181fd37e8.

PMID:
21037441
[PubMed - indexed for MEDLINE]
2.

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.

Breeman WA, de Blois E, Sze Chan H, Konijnenberg M, Kwekkeboom DJ, Krenning EP.

Semin Nucl Med. 2011 Jul;41(4):314-21. doi: 10.1053/j.semnuclmed.2011.02.001. Review.

PMID:
21624565
[PubMed - indexed for MEDLINE]
3.

PET imaging in neuroendocrine tumors: current status and future prospects.

Basu S, Kumar R, Rubello D, Fanti S, Alavi A.

Minerva Endocrinol. 2008 Sep;33(3):257-75. Review.

PMID:
18846029
[PubMed - indexed for MEDLINE]
4.

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.

Kwekkeboom DJ, Kam BL, van Essen M, Teunissen JJ, van Eijck CH, Valkema R, de Jong M, de Herder WW, Krenning EP.

Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73. doi: 10.1677/ERC-09-0078. Print 2010 Mar. Review.

PMID:
19995807
[PubMed - indexed for MEDLINE]
Free Article
5.

Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer.

Alberini JL, Edeline V, Giraudet AL, Champion L, Paulmier B, Madar O, Poinsignon A, Bellet D, Pecking AP.

J Surg Oncol. 2011 May 1;103(6):602-6. doi: 10.1002/jso.21695. Review.

PMID:
21480254
[PubMed - indexed for MEDLINE]
6.

[PET-CT for neuroendocrine tumors and nuclear medicine therapy options].

Scheidhauer K, Miederer M, Gaertner FC.

Radiologe. 2009 Mar;49(3):217-23. doi: 10.1007/s00117-008-1784-9. Review. German.

PMID:
19296068
[PubMed - indexed for MEDLINE]
7.

Accuracy of whole-body PET and PET-CT in initial M staging of head and neck cancer: a meta-analysis.

Xu GZ, Zhu XD, Li MY.

Head Neck. 2011 Jan;33(1):87-94. doi: 10.1002/hed.21400. Review.

PMID:
20848421
[PubMed - indexed for MEDLINE]
8.

Imaging neuroendocrine tumours with radionuclide techniques.

Gnanasegaran G, O'Doherty MJ.

Minerva Endocrinol. 2008 Jun;33(2):105-26. Review.

PMID:
18425057
[PubMed - indexed for MEDLINE]
Free Article
9.

Clinical applications of Gallium-68.

Banerjee SR, Pomper MG.

Appl Radiat Isot. 2013 Jun;76:2-13. doi: 10.1016/j.apradiso.2013.01.039. Epub 2013 Feb 20. Review.

PMID:
23522791
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Functional imaging of neuroendocrine tumours with PET.

Mottaghy FM, Reske SN.

Pituitary. 2006;9(3):237-42. Review.

PMID:
17036194
[PubMed - indexed for MEDLINE]
11.

Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.

Schmidt GP, Kramer H, Reiser MF, Glaser C.

Top Magn Reson Imaging. 2007 Jun;18(3):193-202. Review.

PMID:
17762383
[PubMed - indexed for MEDLINE]
12.

Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.

Sundin A.

Best Pract Res Clin Gastroenterol. 2012 Dec;26(6):803-18. doi: 10.1016/j.bpg.2012.12.004. Review.

PMID:
23582920
[PubMed - indexed for MEDLINE]
13.

Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis.

Treglia G, Castaldi P, Rindi G, Giordano A, Rufini V.

Endocrine. 2012 Aug;42(1):80-7. doi: 10.1007/s12020-012-9631-1. Epub 2012 Feb 20. Review.

PMID:
22350660
[PubMed - indexed for MEDLINE]
14.

Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Billé A, Pelosi E, Skanjeti A, Arena V, Errico L, Borasio P, Mancini M, Ardissone F.

Eur J Cardiothorac Surg. 2009 Sep;36(3):440-5. doi: 10.1016/j.ejcts.2009.04.003. Epub 2009 May 22. Review.

PMID:
19464906
[PubMed - indexed for MEDLINE]
15.

Less frequent requests for In-111 pentreotide and its brothers of endocrinological interest.

Cuccurullo V, Cascini GL, Tamburrini O, Mansi L, Rotondo A.

Minerva Endocrinol. 2011 Mar;36(1):41-52. Review.

PMID:
21460786
[PubMed - indexed for MEDLINE]
16.

The role of hybrid SPECT-CT in oncology: current and emerging clinical applications.

Chowdhury FU, Scarsbrook AF.

Clin Radiol. 2008 Mar;63(3):241-51. doi: 10.1016/j.crad.2007.11.008. Epub 2008 Jan 14. Review.

PMID:
18275863
[PubMed - indexed for MEDLINE]
17.

Imaging of neuroendocrine tumors.

Rufini V, Calcagni ML, Baum RP.

Semin Nucl Med. 2006 Jul;36(3):228-47. Review.

PMID:
16762613
[PubMed - indexed for MEDLINE]
18.

Staging and follow-up of gastrointestinal tumors with PET/CT.

Rosenbaum SJ, Stergar H, Antoch G, Veit P, Bockisch A, Kühl H.

Abdom Imaging. 2006 Jan-Feb;31(1):25-35. Review.

PMID:
16333707
[PubMed - indexed for MEDLINE]
19.

Contemporary nuclear medicine imaging of neuroendocrine tumours.

Wong KK, Waterfield RT, Marzola MC, Scarsbrook AF, Chowdhury FU, Gross MD, Rubello D.

Clin Radiol. 2012 Nov;67(11):1035-50. doi: 10.1016/j.crad.2012.03.019. Epub 2012 May 23. Review.

PMID:
22633086
[PubMed - indexed for MEDLINE]
20.

Standard imaging techniques for neuroendocrine tumors.

Bushnell DL, Baum RP.

Endocrinol Metab Clin North Am. 2011 Mar;40(1):153-62, ix. doi: 10.1016/j.ecl.2010.12.002. Review.

PMID:
21349416
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk